When.com Web Search

  1. Ads

    related to: new drug for migraine headaches over the counter

Search results

  1. Results From The WOW.Com Content Network
  2. This New Nasal Spray Could Provide Migraine Relief in ... - AOL

    www.aol.com/nasal-spray-could-migraine-relief...

    Zavzpret is a new nasal spray to treat migraine headaches in adults. But how does the medication work and who should try the new FDA-approved medication?

  3. FDA approves Pfizer's new nasal spray treatment for migraines

    www.aol.com/entertainment/fda-approves-pfizers...

    The drug has shown in clinical trial data to provide rapid pain relief in as fast as 15 minutes for migraine sufferers, with relief lasting up to 48 hours, Pfizer said. ... Pfizer said. Migraines ...

  4. New Startups and Innovations Are Starting To Give Migraine ...

    www.aol.com/startups-innovations-starting...

    Migraine is a brain disorder that causes your neurons (i.e., the nerves in your brain) to become “hyperactive,” explains Cynthia Armand, MD, a migraine specialist for the Montefiore Health ...

  5. Management of migraine - Wikipedia

    en.wikipedia.org/wiki/Management_of_migraine

    Rescue treatment involves acute symptomatic control with medication. [4] Recommendations for rescue therapy of migraine include: (1) migraine-specific agents such as triptans, CGRP antagonists, or ditans for patients with severe headaches or for headaches that respond poorly to analgesics, (2) non-oral (typically nasal or injection) route of administration for patients with vomiting, (3) avoid ...

  6. Butalbital/acetaminophen - Wikipedia

    en.wikipedia.org/wiki/Butalbital/acetaminophen

    Butalbital/acetaminophen, sold under the brand name Butapap among others, is a combination medication used to treat tension headaches and migraine headaches. [1] [4] [5] It contains butalbital, a barbiturate and paracetamol (acetaminophen), an analgesic. [4] Versions also containing caffeine are sold under the brand name Fioricet among others. [6]

  7. Atogepant - Wikipedia

    en.wikipedia.org/wiki/Atogepant

    Atogepant demonstrated efficacy in two phase 3 trials (ADVANCE and PROGRESS) by significantly reducing monthly migraine days, acute medication use, and improving quality of life in patients with episodic and chronic migraine over 12 weeks compared to placebo. [13] Common side effects included nausea, constipation, and fatigue/somnolence.

  1. Ads

    related to: new drug for migraine headaches over the counter